These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 26510686)

  • 61. MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Klassen LMB; Chequin A; Manica GCM; Biembengut IV; Toledo MB; Baura VA; de O Pedrosa F; Ramos EAS; Costa FF; de Souza EM; Klassen G
    Gene; 2018 Feb; 642():461-466. PubMed ID: 29162512
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour.
    Wong EM; Joo JE; McLean CA; Baglietto L; English DR; Severi G; Wu HC; Terry MB; Hopper JL; Milne RL; Giles GG; Southey MC
    Breast Cancer Res Treat; 2016 Nov; 160(1):173-180. PubMed ID: 27604360
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of methylation profiling in cancerous and their corresponding normal tissues from korean patients with breast cancer.
    Jung EJ; Kim IS; Lee EY; Kang JE; Lee SM; Kim DC; Kim JY; Park ST
    Ann Lab Med; 2013 Nov; 33(6):431-40. PubMed ID: 24205493
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Altered transcription and expression of PTEN in breast tumors: is it regulated by hypermethylation?
    Shetty PJ; Pasupuleti N; Chava S; Nasaruddin K; Hasan Q
    Breast Dis; 2011; 33(1):27-33. PubMed ID: 21846942
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 68. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
    Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors.
    Li Z; Chen B; Wu Y; Jin F; Xia Y; Liu X
    BMC Cancer; 2010 Mar; 10():98. PubMed ID: 20230646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Agglomerative epigenetic aberrations are a common event in human breast cancer.
    Novak P; Jensen T; Oshiro MM; Watts GS; Kim CJ; Futscher BW
    Cancer Res; 2008 Oct; 68(20):8616-25. PubMed ID: 18922938
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Conserved role of intragenic DNA methylation in regulating alternative promoters.
    Maunakea AK; Nagarajan RP; Bilenky M; Ballinger TJ; D'Souza C; Fouse SD; Johnson BE; Hong C; Nielsen C; Zhao Y; Turecki G; Delaney A; Varhol R; Thiessen N; Shchors K; Heine VM; Rowitch DH; Xing X; Fiore C; Schillebeeckx M; Jones SJ; Haussler D; Marra MA; Hirst M; Wang T; Costello JF
    Nature; 2010 Jul; 466(7303):253-7. PubMed ID: 20613842
    [TBL] [Abstract][Full Text] [Related]  

  • 72. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
    Augoff K; McCue B; Plow EF; Sossey-Alaoui K
    Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Association between promoter hypermethylation of the DACT2 gene and tumor stages in breast cancer.
    Marusa Borgonio-Cuadra V; Miranda-Duarte A; Rojas-Toledo X; Garcia-Hernandez N; Alfredo Sierra-Ramirez J; Cardenas-Garcia M; Elena Hernandez-Caballero M
    J BUON; 2018; 23(2):361-365. PubMed ID: 29745077
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
    Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
    Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol.
    Medina-Aguilar R; Pérez-Plasencia C; Marchat LA; Gariglio P; García Mena J; Rodríguez Cuevas S; Ruíz-García E; Astudillo-de la Vega H; Hernández Juárez J; Flores-Pérez A; López-Camarillo C
    PLoS One; 2016; 11(6):e0157866. PubMed ID: 27355345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
    Otani Y; Miyake T; Kagara N; Shimoda M; Naoi Y; Maruyama N; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Cancer Sci; 2014 Oct; 105(10):1369-76. PubMed ID: 25155055
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer.
    Bianco T; Chenevix-Trench G; Walsh DC; Cooper JE; Dobrovic A
    Carcinogenesis; 2000 Feb; 21(2):147-51. PubMed ID: 10657950
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
    Hasan TN; Leena Grace B; Shafi G; Syed R
    Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
    Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
    Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
    [No Abstract]   [Full Text] [Related]  

  • 80. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
    Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
    Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.